Early Recognition and Response to Increases in Surgical Site Infections Using Optimized Statistical Process Control Charts: The Early 2RIS Study



Status:Recruiting
Conditions:Infectious Disease, Hospital
Therapuetic Areas:Immunology / Infectious Diseases, Other
Healthy:No
Age Range:Any
Updated:3/31/2019
Start Date:March 6, 2017
End Date:February 2020
Contact:Katherine R Foy, RN
Email:katherine.foy@duke.edu
Phone:919-668-3833

Use our guide to learn which trials are right for you!

Early Recognition and Response to Increases in Surgical Site Infections Using Optimized Statistical Process Control Charts

The purpose of this quality improvement study is to measure the effectiveness of surveillance
using optimized statistical process control (SPC) methods and feedback on rates of surgical
site infection (SSI) compared to traditional surveillance and feedback.

The primary objective is to determine if hospital clusters randomized to receive feedback
from optimized SPC surveillance methods collectively have lower rates of SSI compared to
hospital clusters randomized to receiving feedback from traditional surveillance methods.
Secondary objectives are 1) to estimate and compare the number of signals identified using
optimized SPC methods and traditional surveillance methods; 2) to estimate and compare the
time and effort required to investigate signals generated using optimized SPC methods and
traditional surveillance methods; and 3) to estimate the number and proportion of
false-positive signals identified using optimized SPC methods and traditional surveillance
methods.

The Early 2RIS study will be a prospective, multicenter cluster randomized controlled trial
using stepped wedge design. The active component of the quality improvement study will be
performed in 29 DICON hospitals over three years, from March 2017 through February 2020.
Clusters randomized to intervention will receive feedback on increasing rates of SSI
identified through optimized SPC methods. This intervention is expected to decrease the
subsequent rate of SSIs by closing the feedback loop on SSI outcomes.

Participating study hospitals will all be members of DICON, a network of 43 community
hospitals in North Carolina, South Carolina, Georgia, Florida, and Virginia that provides
community hospitals access to consultative services from infection prevention experts, data
analyses and benchmarking, and educational materials designed by faculty from Duke. This
study is considered part of routine quality improvement measures and a part of previously
established agreements between DICON and the community hospitals. Data flow and communication
are outlined in detail in approved protocols determined to be exempt research by the DUHS
IRB. Briefly, existing clinical data are extracted from participating hospitals' electronic
medical record into discrete files according to DICON specifications. Then a
de-identification process removes direct patient identifiers into a limited dataset.

The majority of data collection will occur through methods already developed and utilized by
study hospitals. In brief, each hospital routinely submits limited datasets to the DICON
Surgical Surveillance Database, including the following variables: hospital, type of
procedure, patient identifier, date of procedure, age, sex, surgeon identifier, start/stop
times, ASA score, wound class, risk index, SSI (Yes/No), date of infection, type of SSI,
location at diagnosis and organism. No identifiable patient or surgeon data are transmitted
to the DICON Surgical Database. Data definitions and data collection methods are standardized
across DICON hospitals. Following signal adjudication, additional data will be collected in a
REDCap database to document actions and rationale.


Inclusion Criteria:

- All patients who undergo one of 13 targeted procedures in 29 DICON study hospitals
will be eligible for inclusion. The 13 targeted procedures include coronary artery
bypass graft, cardiac valve replacement, colon surgery, herniorrhapy, knee
arthroplasty, hip arthroplasty, Cesarean section, abdominal hysterectomy, vaginal
hysterectomy, spinal fusion, laminectomy, carotid endarterectomy, and peripheral
venous bypass. These procedures were selected because they are frequently performed in
community hospitals and/or are associated with particularly adverse outcomes if
complicated by SSI. Eligible procedures will be categorized by procedure type at each
hospital using ICD9 codes published by the NHSN, per routine DICON activities. Six
clusters were constructed from these procedures to ensure that surgeons who perform
similar types of procedures were grouped together to limit potential bias. These
clusters are labeled as Spine, GI, OB/GYN, Ortho, Vascular, and Cardiac. These
clusters are the units for randomization and analysis.

Exclusion Criteria:

- DICON hospitals that did not submit a letter of support for participating in the study
will be excluded. Patients not undergoing one of these 13 procedure types at the 29
study hospitals will be excluded from the analysis.
We found this trial at
1
site
Durham, North Carolina
Principal Investigator: Deverick Anderson, MD
Phone: 919-668-3833
?
mi
from
Durham, NC
Click here to add this to my saved trials